Malaysia's E-cigarette Legalization Still in Question

Aug.09.2022
Malaysia's E-cigarette Legalization Still in Question
The legalization of e-cigarettes sales in Malaysia faces challenges as the proposed "Generation End" anti-smoking bill is under review.

The main advocacy organization in the region, MOVE (Malaysia Vape Entity), has stated that the legalization of electronic cigarette sales in Malaysia still faces challenges, following unexpected turns prior to the Parliamentary elections.


Samsul Kamal Ariffin, the CEO of MOVE, has announced that the proposed "end intergenerational smoking" bill has been referred to a special committee in parliament for further scrutiny, which he considers to be positive news.


We are concerned that electronic cigarettes will be included in this anti-smoking bill, which will result in strict regulations and criminalization of consumers and retailers. Members of the specialized committee now have the opportunity to remove electronic cigarettes and non-combustible products from the legislation and treat them as tools for harm reduction in a completely different manner," said Mr. Alifin.


The date for Malaysia's general election is yet to be confirmed. However, if the next parliamentary session is held earlier, a select committee will take action to prepare a statement on its proposed amendments. MOVE will have a representative serving as a member of this special committee.


Similar to current legislation in New Zealand, Malaysia's proposed "intergenerational end" bill seeks to ban the sale of cigarettes and tobacco products to anyone born after 2007. However, unlike New Zealand, Malaysia's Health Minister also suggests adding electronic cigarette products to the intergenerational ban.


If Malaysia aims to reduce its overall smoking rate to below 5% by 2040, a ban on electronic cigarettes would not be able to achieve that goal. New Zealand has a smoking rate that is less than half of ours because they have become increasingly strict on smoking while only regulating the retail channels of adult e-cigarette products. New Zealand will likely achieve a smoke-free status at least a generation earlier than us because their approach to smoking and e-cigarette use is vastly different. If we want to save lives, Malaysia must do the same," he said.


In April, advocates for tobacco harm reduction (THR) were encouraged when regulations for electronic cigarette devices were announced to take effect on August 3rd. They had been lobbying for this to happen before the legalization of electronic cigarette sales, as have other THR supporters for many years.


We were concerned when the Health Minister proposed the "legacy of generations" bill on August 2nd and intended to pass it before parliament adjourned. Fortunately, enough members of parliament fought back, and the select committee or the next parliament can now regulate e-cigarettes through separate legislation. This is what needs to happen, and I believe it will.


As evidenced by 70 countries, the THR method is effective. Banning e-cigarettes will only harm smokers. Regulating e-cigarettes will provide a viable and less harmful alternative for smokers, not to mention much-needed tax revenue for Malaysia," said Mr. Alifin.


For the past decade, it has been a black market for electronic cigarette users in Malaysia, with unapproved products being untaxed and no safety guarantees for local consumers regarding product standards.


According to Mr. Alifin, providing a feasible, safe, and legal way for the 21% of Malaysians who smoke to improve their health and well-being is crucial. Electronic cigarettes are believed to be 95% less harmful than combustible tobacco. Making safer nicotine products legally available is the only way to significantly reduce Malaysia's unnecessary high smoking rates and save tens of thousands of lives each year.


The Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA) has endorsed the legalization and regulation of e-cigarette sales in Malaysia, believing it will lead to a significant reduction in smoking rates.


MOVE continues to work with political figures and health officials in Malaysia to provide them with necessary information and support to effectively tackle the country's smoking epidemic. CAPHRA believes that the unsuccessful ban on e-cigarettes in Malaysia will be lifted in the next few months and there will be no turning back, said Nancy Lucas, CAPHRA's Executive Coordinator.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS. 2FIRSTS also cannot confirm the truthfulness or accuracy of the content of the article. The compilation of this article is solely for industry exchange and research purposes.


Due to limitations in translation proficiency, the translated article may not fully capture the original author's intended meaning. Therefore, please refer to the original text for accuracy.


2FIRSTS aligns completely with the stance and position of the Chinese government on any domestic, cross-strait, or foreign related issues.


The compilation of information is owned by the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
U.S. Military Could Test Nicotine Pouches and Vapes for Smoking Cessation as Washington Examiner Cites ZYN and Potential $4 Billion Reduction in Related Defense Costs
The House-passed FY2027 National Defense Authorization Act includes a provision authorizing the defense secretary to conduct a one-year smoking-cessation pilot for active-duty service members. Section 707 lists counseling, nicotine gum and patches alongside what the bill calls "electric nicotine delivery systems," nicotine pouches and heat-not-burn products. A recent Washington Examiner op-ed cited ZYN as an example in arguing for the provision, but the legislation does not name any commercial brand or supplier. ZYN is made by PMI-owned Swedish Match USA, with specified products holding FDA marketing authorizations and modified risk orders.
Sep.20
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
JTI Korea launched the Ploom AURA Teal Electric Pop limited edition in South Korea on September 1, 2026, marking the first dual-color design in the Ploom AURA range. The device combines a dark green body with teal accents and is accompanied by matching Front Panel, Back Cover and Pocket Bag accessories. The standalone device is priced at KRW 29,000, with three additional device-and-accessory bundles available. The release continues JTI Korea's use of limited colorways and interchangeable accessories to expand the Ploom AURA portfolio without introducing a new hardware platform.
Sep.03
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
Germany collected €9.789 billion in total tobacco tax revenue from January through August 2026, down 10.8% from a year earlier, according to the Federal Ministry of Finance. Germany's tobacco tax base covers not only cigarettes and fine-cut tobacco but also heated tobacco and vaping liquids taxed as tobacco substitutes. The German Association of the Tobacco Industry and Novel Products, or BVTE, citing federal statistical data, said tax-paid cigarette volume fell 12.6% to 40.6 billion sticks. BVTE is using the latest figures to argue against further tax increases planned from 2027 through 2030, while Germany's parliament is scheduled to hold a first reading of the bill on September 24.
Sep.23
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10